MedTrace Logo

Suicide Prevention for Patients With Chronic Pain

NCT04490265 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-07-24

Study results available
· View outcomes & findings →

Summary

Patients with chronic pain and moderate suicide risk (n=60) will be randomized to receive remote-PST or remote-supportive psychotherapy. We will assess problem-solving deficits through self-report, objective neuropsychological assessment and caregiver report. We have used an adaptive design so that if there is strong evidence for target engagement, we will continue with the trial as a fully powered clinical trial (i.e., the end of the current proposal will act as the interim assessment) to the determine the efficacy of remote PST for patients with chronic pain and moderate suicide risk (n=190) to improve suicide outcomes.

Conditions

Interventions

BEHAVIORAL

Problem-solving treatment

included in arm descriptions

BEHAVIORAL

Supportive Psychotherapy

included in arm descriptions

Sponsors & Collaborators

  • Rutgers University

    collaborator OTHER

  • Veterans BioMedical Research Institute

    lead OTHER

Principal Investigators

  • Lisa M McAndrew, PhD · VA NJHCS

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-20
Primary Completion
2023-12-27
Completion
2023-12-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04490265 on ClinicalTrials.gov